Singapore-based Telehealth Platform ORA Raises $10 Million in Series A Funding Round

Singapore’s telehealth startup, ORA, has successfully raised $10 million in its recent Series A funding round. The funding was led by well-known venture capital firms TNB Aura and Antler, with notable involvement from Gobi Partners, Kairous Capital, and GMA Ventures. With this latest injection of capital, the round brings ORA’s total funding raised to over $17 million. 

The telehealth platform ORA has established itself as a prominent player in the Southeast Asian market, offering comprehensive telemedicine services. Since its launch in 2021, ORA has experienced remarkable growth, delivering over 250,000 consultations and maintaining a consistent upward trajectory.

Charles Wong, founding partner at TNB Aura, expressed his confidence in ORA’s unique approach, stating, “The company’s focus on specialized healthcare verticals, including sensitive topics, combined with its direct-to-patient strategy, has enabled it to stand out in the market. Additionally, ORA’s strong financial performance and ability to cater to the specific needs of patients throughout the entire value chain further contribute to its success.”

With the younger urban population accounting for 36% of the total population and projected to represent half of the population by 2030, ORA recognizes the importance of establishing a strong relationship with this demographic. The founder of ORA, Pour, emphasized the significance of earning the trust of individuals in their 20s and 30s early on, as it allows the company to remain relevant in addressing their evolving healthcare needs as they age.

The Singapore based platform predominantly caters to a young demographic, with 90% of its patients under the age of 38 seeking medical treatment for the first time through online channels. These individuals prioritize flexibility and efficiency in their healthcare experience, which aligns with ORA’s telemedicine approach.

As a result, the startup is committed to ensuring seamless user experience for its predominantly millennial user base, particularly those residing in urban areas. Offering specialized services tailored to specific health issues such as women’s health, men’s health, and skincare, ORA operates an end-to-end platform that encompasses consultations, prescription delivery, and post-care services. 

By focusing on specialized healthcare verticals and adopting a direct-to-patient approach, ORA has positioned itself to cater to the unique requirements of its demographic while ensuring its long-term viability in the rapidly growing telehealth market.

Additionally, ORA has introduced three brands catering to specific healthcare needs. Modules, a pioneering online dermatology platform, offers personalized prescription skincare with an impressive selection of 676 unique formulations. 

With the recent infusion of funds from its Series A round, ORA is set to embark on a path of expansion into new markets, both domestically and internationally. In the coming months, ORA’s brands are scheduled to debut in 1,300 tier-one retail stores, making their accessible and medically-backed product range readily available to a wider consumer base. 

Besides, ORA is exploring opportunities to establish a presence in the Gulf Cooperation Council (GCC) countries, including Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.

This strategic expansion into new territories, coupled with the development of innovative healthcare products, reflects ORA’s commitment to meeting the evolving needs of patients and expanding its market reach.